Skip Navigation



Carcinogenesis Advance Access published online on June 12, 2007

Carcinogenesis, doi:10.1093/carcin/bgm128
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
28/11/2382    most recent
bgm128v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Yang, S.
Right arrow Articles by Meyskens, F. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, S.
Right arrow Articles by Meyskens, F. L., Jr.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Redox Effector Factor-1, Combined with Reactive Oxygen Species, Plays an Important Role in the Transformation of JB6 Cells

Sun Yang, Bobbye Misner, Rita Chiu and Frank L. Meyskens, Jr.*

Departments of Medicine (Hematology/Oncolgoy Division) and Biological Chemistry, Chao Family Comprehensive Cancer Center, School of Medicine, University of California Irvine 101 The City Drive South, Orange, California 92868

* Address reprint requests to Frank L. Meyskens Jr., M.D., Professor of Medicine and Biology Chemistry, College of Medicine, University of California, Irvine, 101 The City Drive South, Bldg. 56, Room 215, Orange, CA 92868. Phone: (714)456-6310. Fax: (714)456-2240. E-mail: FLMeyske{at}uci.edu

Apurinic/apyrimidinic endonuclease/redox effector factor-1 (APE1/Ref-1) is a multifunctional protein involved both in DNA base excision repair and redox regulation. Studies have suggested that abnormal APE/Ref-1 levels and/or activities are associated with tumor progression and sensitivities to treatment, but no direct evidence has yet been published regarding the role of Ref-1 in malignant transformation. We utilized the well-documented tumor promotor-sensitive JB6 mouse epithelial cell model, as well as new transformants (by UVB, H2O2 or Cadmium) to study this phenomenon.

Significant increases of ROS were observed in JB6P+ and all the transformants compared to promotor-resistant JB6P- cells. These increases were paralleled by a sustained elevation of Ref-1 expression. Further analysis exhibited a strong inverse correlation between oxidative DNA lesions (8-oxo-dG) and Ref-1 levels in all JB6 cells. Notably, apoptosis occurred after knockdown of Ref-1 by siRNA, demonstrated by a 2-fold increase of annexin V-positive JB6P+ cells. Ref-1 depletion also inhibited TPA-induced anchorage-independent growth of JB6P+ by 50% and reduced the colony numbers of JB6P+/H2O2 and JB6P+/Cd cells. Mechanistic studies revealed that Ref-1 reduction was associated with an increase of intracellular ROS levels and a marked decrease of AP-1 transcription activities in JB6P+/H2O2 cells.

This is the first report of the novel role of Ref-1 in cellular transformation. Based on the data presented here, we propose that induction of Ref-1, serving as an adaptive response to elevated ROS, plays a critical role in transformation and protects cells from excess ROS stresses through both DNA repair and activation of transcription factors such as AP-1.

Key Words: ROS • Ref-1/APE • JB6P cells • transformation • UVB

Received February 6, 2007; revised April 13, 2007; accepted May 17, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
FASEB J.Home page
J. Lu, S. Zhang, D. Chen, H. Wang, W. Wu, X. Wang, Y. Lei, J. Wang, J. Qian, W. Fan, et al.
Functional characterization of a promoter polymorphism in APE1/Ref-1 that contributes to reduced lung cancer susceptibility
FASEB J, October 1, 2009; 23(10): 3459 - 3469.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M.-H. Kim, H.-B. Kim, S. Acharya, H.-M. Sohn, J. Y. Jun, I.-Y. Chang, and H. J. You
Ape1/Ref-1 Induces Glial Cell-Derived Neurotropic Factor (GDNF) Responsiveness by Upregulating GDNF Receptor {alpha}1 Expression
Mol. Cell. Biol., April 15, 2009; 29(8): 2264 - 2277.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Q. Wei, H. Jiang, C. P. Matthews, and N. H. Colburn
Sulfiredoxin is an AP-1 target gene that is required for transformation and shows elevated expression in human skin malignancies
PNAS, December 16, 2008; 105(50): 19738 - 19743.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
Z. Yang, S. Yang, B. J. Misner, R. Chiu, F. Liu, and F. L. Meyskens Jr.
Nitric oxide initiates progression of human melanoma via a feedback loop mediated by apurinic/apyrimidinic endonuclease-1/redox factor-1, which is inhibited by resveratrol
Mol. Cancer Ther., December 1, 2008; 7(12): 3751 - 3760.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
K. Ando, S. Hirao, Y. Kabe, Y. Ogura, I. Sato, Y. Yamaguchi, T. Wada, and H. Handa
A new APE1/Ref-1-dependent pathway leading to reduction of NF-{kappa}B and AP-1, and activation of their DNA-binding activity
Nucleic Acids Res., August 1, 2008; 36(13): 4327 - 4336.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
G.-M. Zou and A. Maitra
Small-molecule inhibitor of the AP endonuclease 1/REF-1 E3330 inhibits pancreatic cancer cell growth and migration
Mol. Cancer Ther., July 1, 2008; 7(7): 2012 - 2021.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.